Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation. Niskala A, Heijman J, Dobrev D, Jespersen T, et al. Br J Pharmacol 2024 Jun 15. doi: 10.1111/bph.16470.

Read + Share

Amedeo Smart

Independent Medical Education

Niskala A, Heijman J, Dobrev D, Jespersen T, et al. Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation. Br J Pharmacol 2024 Jun 15. doi: 10.1111/bph.16470.
PMID: 38877789